These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 34019837)

  • 1. Cervical cancer screening outcomes in Zambia, 2010-19: a cohort study.
    Pry JM; Manasyan A; Kapambwe S; Taghavi K; Duran-Frigola M; Mwanahamuntu M; Sikazwe I; Matambo J; Mubita J; Lishimpi K; Malama K; Bolton Moore C
    Lancet Glob Health; 2021 Jun; 9(6):e832-e840. PubMed ID: 34019837
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Utilization of cervical cancer screening services and trends in screening positivity rates in a 'screen-and-treat' program integrated with HIV/AIDS care in Zambia.
    Mwanahamuntu MH; Sahasrabuddhe VV; Blevins M; Kapambwe S; Shepherd BE; Chibwesha C; Pfaendler KS; Mkumba G; Vwalika B; Hicks ML; Vermund SH; Stringer JS; Parham GP
    PLoS One; 2013; 8(9):e74607. PubMed ID: 24058599
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Population-level scale-up of cervical cancer prevention services in a low-resource setting: development, implementation, and evaluation of the cervical cancer prevention program in Zambia.
    Parham GP; Mwanahamuntu MH; Kapambwe S; Muwonge R; Bateman AC; Blevins M; Chibwesha CJ; Pfaendler KS; Mudenda V; Shibemba AL; Chisele S; Mkumba G; Vwalika B; Hicks ML; Vermund SH; Chi BH; Stringer JS; Sankaranarayanan R; Sahasrabuddhe VV
    PLoS One; 2015; 10(4):e0122169. PubMed ID: 25885821
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of Cervical Cancer and Clinical Management of Women Screened positive using visual inspection with acetic acid and Cervicography in selected public sector health facilities of Manicaland and Midlands provinces of Zimbabwe, 2021.
    Tachiwenyika E; Dhodho M; Muchedzi A; Sibanda TP; Mupanguri C; Mukungunugwa S; Mhangara M; Ganje N; Tapera T; Samushonga T; Muzondo M; Dube S; Tafuma T; Chingombe B; Maravanyika A; Nyamundaya T
    PLoS One; 2023; 18(11):e0294115. PubMed ID: 38019889
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Higher educational attainment associated with reduced likelihood of abnormal cervical lesions among Zambian women - a cross sectional study.
    Hamoonga TE; Likwa RN; Musonda P; Michelo C
    BMC Cancer; 2017 Oct; 17(1):681. PubMed ID: 29029626
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Utilization and outcomes of cervical cancer screening services in Harare City, 2012-2016: a secondary data analysis.
    Gabaza C; Chonzi P; Chadambuka A; Shambira G; Juru TP; Gombe NT; Nsubuga P; Tshimanga M
    BMC Health Serv Res; 2019 Jul; 19(1):454. PubMed ID: 31277655
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Screening for cervical cancer among HIV-positive and HIV-negative women in Cameroon using simultaneous co-testing with careHPV DNA testing and visual inspection enhanced by digital cervicography: Findings of initial screening and one-year follow-up.
    Cholli P; Bradford L; Manga S; Nulah K; Kiyang E; Manjuh F; DeGregorio G; Ogembo RK; Orock E; Liu Y; Wamai RG; Sheldon LK; Gona PN; Sando Z; Welty T; Welty E; Ogembo JG
    Gynecol Oncol; 2018 Jan; 148(1):118-125. PubMed ID: 29153541
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of HIV status on non-metastatic cervical cancer progression among patients in Lusaka, Zambia.
    Trejo MJ; Lishimpi K; Kalima M; Mwaba CK; Banda L; Chuba A; Chama E; Msadabwe SC; Bell ML; Harris RB; Jacobs E; Soliman A
    Int J Gynecol Cancer; 2020 May; 30(5):613-618. PubMed ID: 32200353
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cervical cancer screening and treatment, HIV infection, and age: Program implementation in seven regions of Namibia.
    Korn AK; Muzingwani L; O'Bryan G; Ensminger A; Boylan AD; Kafidi EL; Kashali M; Ashipala L; Nitschke AM; Dziuban EJ; Forster N; Eckert LO; O'Malley G
    PLoS One; 2022; 17(2):e0263920. PubMed ID: 35171941
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cervical cancer screening uptake and challenges in Malawi from 2011 to 2015: retrospective cohort study.
    Msyamboza KP; Phiri T; Sichali W; Kwenda W; Kachale F
    BMC Public Health; 2016 Aug; 16(1):806. PubMed ID: 27535359
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factors affecting cervical cancer screening uptake, visual inspection with acetic acid positivity and its predictors among women attending cervical cancer screening service in Addis Ababa, Ethiopia.
    Fentie AM; Tadesse TB; Gebretekle GB
    BMC Womens Health; 2020 Jul; 20(1):147. PubMed ID: 32677933
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of HIV infection on metastatic cervical cancer and age at diagnosis among patients in Lusaka, Zambia.
    Trejo MJ; Soliman AS; Chen Y; Kalima M; Chuba A; Chama E; Mwaba CK; Banda L; Lishimpi K
    Int J Gynaecol Obstet; 2022 Mar; 156(3):521-528. PubMed ID: 34121186
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 'Worse than HIV' or 'not as serious as other diseases'? Conceptualization of cervical cancer among newly screened women in Zambia.
    White HL; Mulambia C; Sinkala M; Mwanahamuntu MH; Parham GP; Moneyham L; Grimley DM; Chamot E
    Soc Sci Med; 2012 May; 74(10):1486-93. PubMed ID: 22459188
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Implementation and Operational Research: Age Distribution and Determinants of Invasive Cervical Cancer in a "Screen-and-Treat" Program Integrated With HIV/AIDS Care in Zambia.
    Kapambwe S; Sahasrabuddhe VV; Blevins M; Mwanahamuntu MH; Mudenda V; Shepherd BE; Chibwesha CJ; Pfaendler KS; Hicks ML; Vermund SH; Stringer JS; Parham GP
    J Acquir Immune Defic Syndr; 2015 Sep; 70(1):e20-6. PubMed ID: 26322673
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence, Predictors, and Same Day Treatment of Positive VIA Enhanced by Digital Cervicography and Histopathology Results in a Cervical Cancer Prevention Program in Cameroon.
    DeGregorio GA; Bradford LS; Manga S; Tih PM; Wamai R; Ogembo R; Sando Z; Liu Y; Schwaiger C; Rao SR; Kalmakis K; Kennedy Sheldon L; Nulah K; Welty E; Welty T; Ogembo JG
    PLoS One; 2016; 11(6):e0157319. PubMed ID: 27280882
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cervical Cancer Screening among Women Receiving Antiretroviral Therapy in a Resource-Limited Environment.
    New-Aaron M; Meza JL; Goedert MH; Kibusi SM; Mkhoi ML; Mayengo CD; Charles J; Shabani S; Musil KM; Cheney A; Sumba S
    Asian Pac J Cancer Prev; 2020 Jul; 21(7):2035-2045. PubMed ID: 32711430
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence and Predictor of Cervical Cancer Screening Service Uptake Among Women Aged 25 Years and Above in Sidama Zone, Southern Ethiopia, Using Health Belief Model.
    Gemeda EY; Kare BB; Negera DG; Bona LG; Derese BD; Akale NB; Kebede KM; Koboto DD; Tekle AG
    Cancer Control; 2020; 27(1):1073274820954460. PubMed ID: 32951445
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differences in Cervical Cancer Screening Knowledge and Practices by HIV Status and Geographic Location: Implication for Program Implementation in Zambia.
    Nyambe N; Hoover S; Pinder LF; Chibwesha CJ; Kapambwe S; Parham G; Subramanian S
    Afr J Reprod Health; 2018 Dec; 22(4):92-101. PubMed ID: 30632726
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Implementing a Fee-for-Service Cervical Cancer Screening and Treatment Program in Cameroon: Challenges and Opportunities.
    DeGregorio G; Manga S; Kiyang E; Manjuh F; Bradford L; Cholli P; Wamai R; Ogembo R; Sando Z; Liu Y; Sheldon LK; Nulah K; Welty T; Welty E; Ogembo JG
    Oncologist; 2017 Jul; 22(7):850-859. PubMed ID: 28536303
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cervical Cancer Screening Positivity Among Women Living With HIV in CDC-PEPFAR Programs 2018-2022.
    McCormick LJ; Gutreuter S; Adeoye O; Alger SX; Amado C; Bay Z; Chirwa CM; Chituwo O; Correia D; Deus M; Dirlikov E; Efuntoye T; Gunde L; Kabaghe A; Kalamya JN; Lorenzoni C; Magesa D; Mate C; Mulokoshi T; Ninsiima JC; Nyangasi M; Nyika P; Pasipamire M; Ssali M; Tefera F; Torre LA; Urso M; Wandira R; Zemburuka B; Montandon M
    J Acquir Immune Defic Syndr; 2023 Dec; 94(4):301-307. PubMed ID: 37643419
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.